{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:54:38Z","timestamp":1790816078956,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/med.0b013e32835ef2fd","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T21:28:35Z","timestamp":1363987715000},"page":"170-179","source":"Crossref","is-referenced-by-count":6,"title":["Primary aldosteronism and potassium channel mutations"],"prefix":"10.1097","volume":"20","author":[{"given":"Michael","family":"Stowasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954-1967.","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lect"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism.","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-3-20211004","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.","volume":"85","author":"Stowasser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ecl.2011.01.007","article-title":"Familial or genetic primary aldosteronism and Gordon syndrome.","volume":"40","author":"Stowasser","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways.","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0303-7207(01)00384-7","article-title":"Role of membrane depolarization and T-type Ca2 channels in angiotensin II and K stimulated aldosterone secretion.","volume":"175","author":"Lotshaw","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/mend.16.3.0788","article-title":"TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells.","volume":"16","author":"Czirjak","year":"2002","journal-title":"Mol Endocrinol"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1074\/jbc.M107138200","article-title":"Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits.","volume":"277","author":"Czirjak","year":"2002","journal-title":"J Biol Chem"},{"key":"R13-3-20211004","first-page":"161","article-title":"Targeting K channels for cancer therapy.","volume":"4","author":"Conti","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.CIR.0000156448.74296.FE","article-title":"Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice.","volume":"112","author":"Sausbier","year":"2005","journal-title":"Circulation"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1073\/pnas.0712000105","article-title":"TASK channel deletion in mice causes primary hyperaldosteronism.","volume":"105","author":"Davies","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-3-20211004","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/HYPERTENSIONAHA.111.189662","article-title":"TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.","volume":"59","author":"Guagliardo","year":"2012","journal-title":"Hypertension"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","article-title":"Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis.","volume":"27","author":"Heitzmann","year":"2008","journal-title":"Embo J"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2009.03738.x","article-title":"The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas.","volume":"73","author":"Nogueira","year":"2010","journal-title":"Clin Endocrinol"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004390050717","article-title":"Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome.","volume":"102","author":"Itoh","year":"1998","journal-title":"Hum Genet"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.hjh.0000209984.28735.fd","article-title":"The functional HERG variant 897T is associated with Conns adenoma.","volume":"24","author":"Sarzani","year":"2006","journal-title":"J Hypertens"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS ONE"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/ERC-12-0022","article-title":"KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conns syndrome.","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr-Relat Cancer"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","article-title":"Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.","volume":"29","author":"Omura","year":"2006","journal-title":"Hypertens Res"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1440-1681.1987.tb00371.x","article-title":"Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis.","volume":"14","author":"Gordon","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1991.tb00306.x","article-title":"Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin.","volume":"34","author":"Tunny","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","article-title":"Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness.","volume":"21","author":"Stowasser","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201306000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T21:40:04Z","timestamp":1715118004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201306000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32835ef2fd","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}